Compare ORIC & NBBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORIC | NBBK |
|---|---|---|
| Founded | 2014 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 783.0M | 718.5M |
| IPO Year | 2020 | N/A |
| Metric | ORIC | NBBK |
|---|---|---|
| Price | $8.56 | $20.02 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 1 |
| Target Price | $19.73 | ★ $23.00 |
| AVG Volume (30 Days) | ★ 1.4M | 212.0K |
| Earning Date | 02-17-2026 | 01-22-2026 |
| Dividend Yield | N/A | ★ 1.42% |
| EPS Growth | N/A | ★ 420.99 |
| EPS | N/A | ★ 1.54 |
| Revenue | N/A | ★ $189,481,000.00 |
| Revenue This Year | N/A | $43.56 |
| Revenue Next Year | N/A | $23.60 |
| P/E Ratio | ★ N/A | $12.79 |
| Revenue Growth | N/A | ★ 30.69 |
| 52 Week Low | $3.90 | $15.09 |
| 52 Week High | $14.93 | $21.58 |
| Indicator | ORIC | NBBK |
|---|---|---|
| Relative Strength Index (RSI) | 39.26 | 47.85 |
| Support Level | $7.84 | $19.37 |
| Resistance Level | $8.92 | $20.53 |
| Average True Range (ATR) | 0.38 | 0.52 |
| MACD | 0.14 | -0.17 |
| Stochastic Oscillator | 67.28 | 29.02 |
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
NB Bancorp Inc operates as the holding company of Needham Bank. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate and multifamily loans, one- to four-family residential real estate loans, construction and land development loans, commercial and industrial loans, and consumer loans.